Market Research Future (MRFR) has presented a detailed study into the global operations in
the global interleukin market and an extensive analysis of the market’s pipeline. The report
presents to readers a clear picture of the current operating conditions in the global interleukin
market by detailing the various factors affecting the product pipeline in the market.
Interleukin is an anti-inflammatory cytokine with several varied functions in the immune
system. It has a key function of stopping inflammation of immune cells by blocking the
production of cytokines. The global interleukin market has grown rapidly over the last few years
due to the growing awareness about the utility of interleukin-10 in the treatment of
autoimmune diseases, in addition to other diseases such as cancer. The increasing prevalence
of autoimmune diseases around the world has been a major driver for the global interleukin-10
market. The increasing prevalence of cancer has also helped the market achieve a steady
growth rate. The interleukin-10 pipeline consists of nearly 20 molecules being studied upon at
present. These include 9 molecules in the preclinical stage, 4 molecules in phase II, and 2
molecules in phase I.
Request Sample Copy:
The increasing emphasis on the development of effective cancer therapeutics is likely to be a
major driver for the global interleukin-10 market over the forecast period. Interleukin-10-based
treatments are used in the treatment of a number of cancer types, including pancreatic cancer,
renal cell carcinoma, and non-small-cell lung cancer. The increasing prevalence of these and
other types of cancer and the increasing expenditure being incurred on cancer treatment is
likely to drive the interleukin-10 market over the forecast period. Cancer is one of the major
challenges facing the healthcare sector at present and is likely to remain a major driver for the
global interleukin-10 market over the forecast period.